newsfilter
← Latest News
Earnings Call Transcripts·

Phase I/II Ifezuntirgene Inilparvovec (AMT-130) Huntington’s Disease Program Update - UNIQURE NV

Good morning and thank you for standing by. My name is Jeanne and I will be your conference operator today. At this time I would like to welcome everyone to the Unicure phase 1 to AMT 130 Huntington's disease program upd

Company
UNIQURE NV
Keywords
UNIQURE NV